{
  "input": {
    "mode": "revise",
    "query": {
      "entity": "Epileptic encephalopathy",
      "relation": "contraindication"
    },
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_levetiracetam",
          "type": "Drug",
          "label": "Levetiracetam",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_valproate",
          "type": "Drug",
          "label": "Valproate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_carbamazepine",
          "type": "Drug",
          "label": "Carbamazepine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_lamotrigine",
          "type": "Drug",
          "label": "Lamotrigine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_topiramate",
          "type": "Drug",
          "label": "Topiramate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_phenytoin",
          "type": "Drug",
          "label": "Phenytoin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_zonisamide",
          "type": "Drug",
          "label": "Zonisamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_lacosamide",
          "type": "Drug",
          "label": "Lacosamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_epileptic_enc",
          "type": "Disease",
          "label": "Epileptic Encephalopathy",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_seizure_control",
          "type": "Pathway",
          "label": "Seizure Control Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_gabapentinoid",
          "type": "Target",
          "label": "Gabapentinoid Receptor",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "phenotype_anticonvulsant_effect",
          "type": "Phenotype",
          "label": "Anticonvulsant Effect",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ot_lev",
          "type": "Target",
          "label": "Levetiracetam Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_lev",
          "type": "Pathway",
          "label": "Levetiracetam Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_lev",
          "type": "Phenotype",
          "label": "Levetiracetam Adverse Phenotype",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_val",
          "type": "Target",
          "label": "Valproate Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_val",
          "type": "Pathway",
          "label": "Valproate Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_val",
          "type": "Phenotype",
          "label": "Valproate Adverse Phenotype",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_car",
          "type": "Target",
          "label": "Carbamazepine Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_car",
          "type": "Pathway",
          "label": "Carbamazepine Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_car",
          "type": "Phenotype",
          "label": "Carbamazepine Adverse Phenotype",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_lam",
          "type": "Target",
          "label": "Lamotrigine Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_lam",
          "type": "Pathway",
          "label": "Lamotrigine Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_lam",
          "type": "Phenotype",
          "label": "Lamotrigine Adverse Phenotype",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_top",
          "type": "Target",
          "label": "Topiramate Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_top",
          "type": "Pathway",
          "label": "Topiramate Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_top",
          "type": "Phenotype",
          "label": "Topiramate Adverse Phenotype",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_levetiracetam",
          "target": "target_gabapentinoid",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知调节抗癫痫药理"
        },
        {
          "source": "drug_valproate",
          "target": "target_gabapentinoid",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知调节抗癫痫药理"
        },
        {
          "source": "drug_carbamazepine",
          "target": "target_gabapentinoid",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知调节抗癫痫药理"
        },
        {
          "source": "drug_lamotrigine",
          "target": "target_gabapentinoid",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知调节抗癫痫药理"
        },
        {
          "source": "drug_topiramate",
          "target": "target_gabapentinoid",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知调节抗癫痫药理"
        },
        {
          "source": "drug_phenytoin",
          "target": "target_gabapentinoid",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知调节抗癫痫药理"
        },
        {
          "source": "drug_zonisamide",
          "target": "target_gabapentinoid",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知调节抗癫痫药理"
        },
        {
          "source": "drug_lacosamide",
          "target": "target_gabapentinoid",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知调节抗癫痫药理"
        },
        {
          "source": "target_gabapentinoid",
          "target": "pathway_seizure_control",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "通路包含癫痫相关机制"
        },
        {
          "source": "pathway_seizure_control",
          "target": "disease_epileptic_enc",
          "relation": "causes",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "机制与疾病相关"
        },
        {
          "source": "drug_levetiracetam",
          "target": "phenotype_anticonvulsant_effect",
          "relation": "modulates",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "影响抗癫痫表型"
        },
        {
          "source": "drug_valproate",
          "target": "phenotype_anticonvulsant_effect",
          "relation": "modulates",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "影响抗癫痫表型"
        },
        {
          "source": "drug_carbamazepine",
          "target": "phenotype_anticonvulsant_effect",
          "relation": "modulates",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "影响抗癫痫表型"
        },
        {
          "source": "drug_lamotrigine",
          "target": "phenotype_anticonvulsant_effect",
          "relation": "modulates",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "影响抗癫痫表型"
        },
        {
          "source": "drug_topiramate",
          "target": "phenotype_anticonvulsant_effect",
          "relation": "modulates",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "影响抗癫痫表型"
        },
        {
          "source": "drug_phenytoin",
          "target": "phenotype_anticonvulsant_effect",
          "relation": "modulates",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "影响抗癫痫表型"
        },
        {
          "source": "drug_zonisamide",
          "target": "phenotype_anticonvulsant_effect",
          "relation": "modulates",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "影响抗癫痫表型"
        },
        {
          "source": "drug_lacosamide",
          "target": "phenotype_anticonvulsant_effect",
          "relation": "modulates",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "影响抗癫痫表型"
        },
        {
          "source": "drug_levetiracetam",
          "target": "n_ot_lev",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "显示出对非靶向的药理活性"
        },
        {
          "source": "n_ot_lev",
          "target": "n_rp_lev",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "与潜在风险通路关联"
        },
        {
          "source": "n_rp_lev",
          "target": "n_adv_lev",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能造成不良表型"
        },
        {
          "source": "n_adv_lev",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        },
        {
          "source": "drug_valproate",
          "target": "n_ot_val",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "显示出对非靶向的药理活性"
        },
        {
          "source": "n_ot_val",
          "target": "n_rp_val",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "与潜在风险通路关联"
        },
        {
          "source": "n_rp_val",
          "target": "n_adv_val",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能造成不良表型"
        },
        {
          "source": "n_adv_val",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        },
        {
          "source": "drug_carbamazepine",
          "target": "n_ot_car",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "显示出对非靶向的药理活性"
        },
        {
          "source": "n_ot_car",
          "target": "n_rp_car",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "与潜在风险通路关联"
        },
        {
          "source": "n_rp_car",
          "target": "n_adv_car",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能造成不良表型"
        },
        {
          "source": "n_adv_car",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        },
        {
          "source": "drug_lamotrigine",
          "target": "n_ot_lam",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "显示出对非靶向的药理活性"
        },
        {
          "source": "n_ot_lam",
          "target": "n_rp_lam",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "与潜在风险通路关联"
        },
        {
          "source": "n_rp_lam",
          "target": "n_adv_lam",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能造成不良表型"
        },
        {
          "source": "n_adv_lam",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        },
        {
          "source": "drug_topiramate",
          "target": "n_ot_top",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "显示出对非靶向的药理活性"
        },
        {
          "source": "n_ot_top",
          "target": "n_rp_top",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "与潜在风险通路关联"
        },
        {
          "source": "n_rp_top",
          "target": "n_adv_top",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能造成不良表型"
        },
        {
          "source": "n_adv_top",
          "target": "H5",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        }
      ],
      "round_index": 3
    },
    "history": {
      "round": 3,
      "last_scores": [
        {
          "hypothesis_id": "H1",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H2",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H3",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H4",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H5",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H6",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H7",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H8",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H9",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H10",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H11",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H12",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H13",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H14",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H15",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H16",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H17",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H18",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H19",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H20",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H21",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H22",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H23",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H24",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H25",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H26",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H27",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H28",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H29",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H30",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H31",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H32",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H33",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H34",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H35",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H36",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H37",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H38",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H39",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H40",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H41",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H42",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H43",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H44",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H45",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H46",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H47",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H48",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H49",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H50",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H51",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H52",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H53",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        },
        {
          "hypothesis_id": "H54",
          "score": 0.02,
          "confidence": "low",
          "uncertainties": [
            "对非靶向的药理活性影响需要进一步验证",
            "安全性风险未完全剖析"
          ]
        }
      ]
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65
    }
  },
  "output": {
    "revisions": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Levetiracetam与癫痫脑病的潜在禁忌",
            "expectation": "分析可能的安全性风险，确定是否存在导致不良表型的潜在机制",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "对Levetiracetam与癫痫脑病的互作进行进一步调查",
          "建立对非靶向药理活性的验证机制和预警系统"
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Valproate与癫痫脑病的潜在禁忌",
            "expectation": "分析可能的安全性风险，确定是否存在导致不良表型的潜在机制",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "对Valproate与癫痫脑病的互作进行进一步调查",
          "建立对非靶向药理活性的验证机制和预警系统"
        ]
      },
      {
        "hypothesis_id": "H3",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Carbamazepine与癫痫脑病的潜在禁忌",
            "expectation": "分析可能的安全性风险，确定是否存在导致不良表型的潜在机制",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "对Carbamazepine与癫痫脑病的互作进行进一步调查",
          "建立对非靶向药理活性的验证机制和预警系统"
        ]
      },
      {
        "hypothesis_id": "H4",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Lamotrigine与癫痫脑病的潜在禁忌",
            "expectation": "分析可能的安全性风险，确定是否存在导致不良表型的潜在机制",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "对Lamotrigine与癫痫脑病的互作进行进一步调查",
          "建立对非靶向药理活性的验证机制和预警系统"
        ]
      },
      {
        "hypothesis_id": "H5",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Topiramate与癫痫脑病的潜在禁忌",
            "expectation": "分析可能的安全性风险，确定是否存在导致不良表型的潜在机制",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "对Topiramate与癫痫脑病的互作进行进一步调查",
          "建立对非靶向药理活性的验证机制和预警系统"
        ]
      }
    ],
    "pruned_hypotheses": [],
    "new_subhypotheses": [],
    "seed_request": {
      "should_regenerate": false,
      "reason": "所有候选的安全性分析需要更深入的验证，不符合再生标准。",
      "n": 4
    }
  }
}